First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat.

Rosa María AntonijoanJuan Manuel Ferrero-CafieroJimena CoimbraMontse PuntesJoan Martínez-ColomerMaría Isabel ArévaloCristina MascaróCesar MolineroCarlos BuesaTamara Maes

Published in: CNS drugs (2021)

EUDRACT No. 2015-003721-33, filed 30 October 2015.

Keyphrases

endothelial cells
induced pluripotent stem cells
pluripotent stem cells
randomized controlled trial
double blind
placebo controlled